1. Home
  2. AMCX vs BBNX Comparison

AMCX vs BBNX Comparison

Compare AMCX & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMC Networks Inc.

AMCX

AMC Networks Inc.

HOLD

Current Price

$11.76

Market Cap

492.0M

ML Signal

HOLD

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$16.53

Market Cap

493.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMCX
BBNX
Founded
1980
2015
Country
United States
United States
Employees
N/A
423
Industry
Cable & Other Pay Television Services
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
492.0M
493.1M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
AMCX
BBNX
Price
$11.76
$16.53
Analyst Decision
Sell
Strong Buy
Analyst Count
4
10
Target Price
$7.33
$23.80
AVG Volume (30 Days)
795.9K
1.4M
Earning Date
05-08-2026
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
132.55
N/A
EPS
N/A
N/A
Revenue
$2,311,801,000.00
N/A
Revenue This Year
N/A
$34.90
Revenue Next Year
N/A
$34.63
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.47
$8.80
52 Week High
$12.52
$32.71

Technical Indicators

Market Signals
Indicator
AMCX
BBNX
Relative Strength Index (RSI) 64.19 58.29
Support Level $9.23 $16.02
Resistance Level N/A $18.20
Average True Range (ATR) 0.68 1.28
MACD 0.16 -0.02
Stochastic Oscillator 79.27 78.28

Price Performance

Historical Comparison
AMCX
BBNX

About AMCX AMC Networks Inc.

AMC Global Media owns several linear TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network,reached 55 million pay TV households in the US at the end of 2025. The firm also had nearly 10.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: